Literature DB >> 16488126

The when and wheres of CDC25 phosphatases.

Rose Boutros1, Christine Dozier, Bernard Ducommun.   

Abstract

The CDC25 phosphatases are key regulators of normal cell division and the cell's response to DNA damage. Earlier studies suggested non-overlapping roles for each isoform during a specific cell cycle phase. However, recent data suggest that multiple CDC25 isoforms cooperate to regulate each cell cycle transition. For instance, although CDC25A was initially thought to exclusively regulate the G(1)-S transition, recent data demonstrate a significant role for CDC25A in the G(2)-M transition. Further evidence demonstrates that in addition to the ATM/ATR-CHK pathway, a p38-MAPKAP pathway is also involved in controlling CDC25 activity during G(2)/M checkpoint activation. Together with the fact that CDC25 overexpression is reported in many cancers, these data highlight the significance of developing specific CDC25 inhibitors for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16488126     DOI: 10.1016/j.ceb.2006.02.003

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  136 in total

1.  The regulatory network of cell-cycle progression is fundamentally different in plants versus yeast or metazoans.

Authors:  Nico Dissmeyer; Annika K Weimer; Lieven De Veylder; Bela Novak; Arp Schnittger
Journal:  Plant Signal Behav       Date:  2010-12-01

2.  A robust protocol to map binding sites of the 14-3-3 interactome: Cdc25C requires phosphorylation of both S216 and S263 to bind 14-3-3.

Authors:  Perry M Chan; Yuen-Wai Ng; Ed Manser
Journal:  Mol Cell Proteomics       Date:  2010-12-28       Impact factor: 5.911

Review 3.  Ubiquitin and SUMO systems in the regulation of mitotic checkpoints.

Authors:  Gustavo J Gutierrez; Ze'ev Ronai
Journal:  Trends Biochem Sci       Date:  2006-05-02       Impact factor: 13.807

4.  Arabidopsis WEE1 kinase controls cell cycle arrest in response to activation of the DNA integrity checkpoint.

Authors:  Kristof De Schutter; Jérôme Joubès; Toon Cools; Aurine Verkest; Florence Corellou; Elena Babiychuk; Els Van Der Schueren; Tom Beeckman; Sergeï Kushnir; Dirk Inzé; Lieven De Veylder
Journal:  Plant Cell       Date:  2007-01-05       Impact factor: 11.277

5.  Female infertility in PDE3A(-/-) mice: polo-like kinase 1 (Plk1) may be a target of protein kinase A (PKA) and involved in meiotic arrest of oocytes from PDE3A(-/-) mice.

Authors:  Weixing Shen; Faiyaz Ahmad; Steven Hockman; John Ma; Hitoshi Omi; Nalini Raghavachari; Vincent Manganiello
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

6.  Inactivation of Rho GTPases with Clostridium difficile toxin B impairs centrosomal activation of Aurora-A in G2/M transition of HeLa cells.

Authors:  Yoshikazu Ando; Shingo Yasuda; Fabian Oceguera-Yanez; Shuh Narumiya
Journal:  Mol Biol Cell       Date:  2007-07-18       Impact factor: 4.138

7.  Emi2 Is Essential for Mouse Spermatogenesis.

Authors:  Lakshmi Gopinathan; Radoslaw Szmyd; Diana Low; M Kasim Diril; Heng-Yu Chang; Vincenzo Coppola; Kui Liu; Lino Tessarollo; Ernesto Guccione; Ans M M van Pelt; Philipp Kaldis
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

8.  PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.

Authors:  Nikolaos Patsoukis; Duygu Sari; Vassiliki A Boussiotis
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

9.  Type I interferons link viral infection to enhanced epithelial turnover and repair.

Authors:  Lulu Sun; Hiroyuki Miyoshi; Sofia Origanti; Timothy J Nice; Alexandra C Barger; Nicholas A Manieri; Leslie A Fogel; Anthony R French; David Piwnica-Worms; Helen Piwnica-Worms; Herbert W Virgin; Deborah J Lenschow; Thaddeus S Stappenbeck
Journal:  Cell Host Microbe       Date:  2014-12-04       Impact factor: 21.023

Review 10.  Biochemical signaling of PD-1 on T cells and its functional implications.

Authors:  Vassiliki A Boussiotis; Pranam Chatterjee; Lequn Li
Journal:  Cancer J       Date:  2014 Jul-Aug       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.